Episode 10: How Trump & RFK Jr Affect AI and Medical Device Cybersecurity Guidelines

How might the second Donald Trump administration and Robert F. Kennedy Jr. impact the medtech cybersecurity world?

In this episode, Christian and Trevor discuss how the Trump administration and RFK Jr.’s policies could reshape medical device cybersecurity and regulation. They explore potential Food and Drug Administration restructuring, the impact of tariffs on China, and new scrutiny on supply chains and AI components.

Key points:

• The Trump administration’s focus on efficiency and deregulation may clash with RFK Jr.’s push for stricter safety rules.
• FDA restructuring is rumored, with potential divisions for food, drugs, and medical devices.
• Increased oversight may make it harder for startups to bring devices to market.
• Tariffs on Chinese components could drive up costs and slow down innovation.
• Cybersecurity concerns around AI models like DeepSeek raise new challenges.
• The potential elimination of the CSRB could shift more cybersecurity responsibilities to private companies.
• Elon Musk’s Department of Government Efficiency (DOGE) and its potential impact on FDA processes.